Francesc Coll

ORCID: 0000-0002-7882-2325
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mycobacterium research and diagnosis
  • Tuberculosis Research and Epidemiology
  • Antimicrobial Resistance in Staphylococcus
  • Bacterial Identification and Susceptibility Testing
  • SARS-CoV-2 and COVID-19 Research
  • Antibiotic Resistance in Bacteria
  • Biochemical and Molecular Research
  • Genomics and Phylogenetic Studies
  • Bacterial biofilms and quorum sensing
  • COVID-19 Clinical Research Studies
  • Microbial Community Ecology and Physiology
  • Diagnosis and treatment of tuberculosis
  • Clostridium difficile and Clostridium perfringens research
  • Bacteriophages and microbial interactions
  • SARS-CoV-2 detection and testing
  • Salmonella and Campylobacter epidemiology
  • Reproductive tract infections research
  • Microbial Metabolism and Applications
  • COVID-19 epidemiological studies
  • RNA and protein synthesis mechanisms
  • Escherichia coli research studies
  • Infectious Diseases and Tuberculosis
  • Agriculture, Soil, Plant Science
  • Antibiotic Use and Resistance
  • Syphilis Diagnosis and Treatment

London School of Hygiene & Tropical Medicine
2016-2025

Wellcome Sanger Institute
2012-2025

University of London
2014-2022

University of Cambridge
2016-2021

University College London
2021

University of Geneva
2019

University of Oxford
2019

Imperial College Healthcare NHS Trust
2019

World Health Organization
2019

Hospital for Tropical Diseases
2016

Abstract Strain-specific genomic diversity in the Mycobacterium tuberculosis complex (MTBC) is an important factor pathogenesis that may affect virulence, transmissibility, host response and emergence of drug resistance. Several systems have been proposed to classify MTBC strains into distinct lineages families. Here, we investigate single-nucleotide polymorphisms (SNPs) as robust (stable) markers genetic variation for phylogenetic analysis. We identify ~92k SNP across a global collection...

10.1038/ncomms5812 article EN cc-by Nature Communications 2014-09-01
Katherine A. Twohig Tommy Nyberg Asad Zaidi Simon Thelwall Mary Sinnathamby and 95 more Shirin Aliabadi Shaun R. Seaman Ross Harris Russell Hope Jamie Lopez Bernal Eileen Gallagher André Charlett Daniela De Angelis Anne M. Presanis Gavin Dabrera Cherian Koshy Amy Ash Emma L. Wise Nathan W. Moore Matilde Mori Nick Cortes Jessica Lynch Stephen P. Kidd Derek Fairley Tanya Curran James P. McKenna Helen Adams Christophe Fraser Tanya Golubchik David Bonsall Mohammed O. Hassan-Ibrahim Cassandra S. Malone Benjamin J. Cogger Michelle Wantoch Nicola Reynolds Ben Warne Joshua Maksimovic Karla Spellman Kathryn McCluggage John P.T. Mo Robert Beer Safiah Afifi Siân Morgan Angela Marchbank Anna Price Christine Kitchen Huw Gulliver Ian Merrick Joel Southgate Martyn F. Guest R. W. Munn Trudy Workman Thomas R. Connor William Fuller Catherine Bresner Luke B. Snell Amita Patel Themoula Charalampous Gaia Nebbia Rahul Batra Jonathan D. Edgeworth Samuel C. Robson Angela H. Beckett David M. Aanensen Anthony Underwood Corin Yeats Khalil Abudahab Ben Taylor Mirko Menegazzo Gemma Clark Darren Smith Manjinder Khakh Vicki M. Fleming Michelle M. Lister Hannah C. Howson‐Wells Louise Berry Tim Boswell Amelia Joseph Iona Willingham Carl Jones Christopher W. Holmes Paul Bird Thomas Helmer Karlie Fallon Julian W. Tang Veena Raviprakash Sharon L. Campbell Nicola Sheriff Victoria Blakey Lesley-Anne Williams Matthew Loose Nadine Holmes Christopher Moore Matthew Carlile Victoria Wright Fei Sang Johnny Debebe Francesc Coll Adrian W. Signell Gilberto Betancor

The SARS-CoV-2 delta (B.1.617.2) variant was first detected in England March, 2021. It has since rapidly become the predominant lineage, owing to high transmissibility. is suspected that associated with more severe disease than previously dominant alpha (B.1.1.7) variant. We aimed characterise severity of compared by determining relative risk hospital attendance outcomes.

10.1016/s1473-3099(21)00475-8 article EN cc-by The Lancet Infectious Diseases 2021-08-28

Abstract Mycobacterium tuberculosis drug resistance (DR) challenges effective disease control. Current molecular tests examine limited numbers of mutations, and although whole genome sequencing approaches could fully characterise DR, data complexity has restricted their clinical application. A library (1,325 mutations) predictive DR for 15 anti-tuberculosis drugs was compiled validated 11 them using genomic-phenotypic from 792 strains. rapid online ‘TB-Profiler’ tool developed to report...

10.1186/s13073-015-0164-0 article EN cc-by Genome Medicine 2015-05-27

To improve understanding of the factors influencing tuberculosis transmission and role pathogen variation, we sequenced all available specimens from patients diagnosed over 15 years in a whole district Malawi. Mycobacterium lineages were assigned networks constructed, allowing ≤10 single nucleotide polymorphisms (SNPs) difference. We defined disease as due to recent infection if network-determined source was within 5 years, assessed transmissibility forward transmissions resulting disease....

10.7554/elife.05166 article EN cc-by eLife 2015-03-02
Timothy M. Walker Paolo Miotto Claudio U. Köser P. W. Fowler Jeff Knaggs and 95 more Zamin Iqbal Martin Hunt Leonid Chindelevitch Maha Farhat Daniela María Cirillo Iñaki Comas James E. Posey Shaheed Vally Omar Tim Peto Anita Suresh Swapna Uplekar Sacha Laurent Rebecca E. Colman Carl‐Michael Nathanson Matteo Zignol Ann Sarah Walker Derrick W. Crook Nazir Ismail Timothy C. Rodwell Timothy M. Walker Adrie J. C. Steyn Ajit Lalvani Alain R. Baulard Alan Christoffels Alberto Mendoza‐Ticona Alberto Trovato Alena Skrahina Alexander S. Lachapelle Alice Brankin Amy S. Piatek Ana Gibertoni Cruz Anastasia Koch Andrea Maurizio Cabibbe Andrea Spitaleri Angela Pires Brandão Angkana Chaiprasert Anita Suresh A. I. Barbova Annelies Van Rie Arash Ghodousi Arnold Bainomugisa Ayan Mandal Aysha Roohi Babak Javid Baoli Zhu Brice Letcher Camilla Rodrigues Camus Nimmo Carl‐Michael Nathanson Carla Duncan Christopher Coulter Christian Utpatel Chunfa Liu Clara Grazian Clare Kong Claudio U. Köser Daniel J. Wilson Daniela María Cirillo Daniela Matias Danielle Jorgensen Danila Zimenkov Darren Chetty David Moore David A. Clifton Derrick W. Crook Dick van Soolingen Dongxin Liu Donna Kohlerschmidt Dráurio Barreira Dumisani Ngcamu David Santos-Lázaro Ellis Kelly Emanuele Borroni Emma Roycroft Emmanuel André Erik C. Böttger Esther Robinson Fabrizio Menardo Flavia F Mendes Frances Jamieson Francesc Coll George F. Gao George William Kasule Gian María Rossolini Gillian Rodger E. Grace Smith Graeme Meintjes Guy Thwaites Harald Hoffmann Heidi Albert Helen Cox Ian F. Laurenson Iñaki Comas Irena Arandjelović Ivan Barilar

Molecular diagnostics are considered the most promising route to achieving rapid, universal drug susceptibility testing for

10.1016/s2666-5247(21)00301-3 article EN cc-by The Lancet Microbe 2022-03-08

The increasing prevalence of E. coli bloodstream infections is a serious public health problem. We used genomic epidemiology in One Health study conducted the East England to examine putative sources associated with human disease. from 1,517 patients were compared 431 isolates livestock farms and meat. Livestock-associated genetically distinct populations based on core genome accessory analyses. Identical antimicrobial resistance genes found isolates, but there was limited overlap mobile...

10.1128/mbio.02693-18 article EN cc-by mBio 2019-01-21

Longitudinal genomic and epidemiological surveillance of methicillin-resistant Staphylococcus aureus in the UK reveals extensive transmission hospitals community.

10.1126/scitranslmed.aak9745 article EN Science Translational Medicine 2017-10-25

Improved molecular diagnostic methods for detection drug resistance in Mycobacterium tuberculosis (MTB) strains are required. Resistance to first- and second- line anti-tuberculous drugs has been associated with single nucleotide polymorphisms (SNPs) particular genes. However, these SNPs can vary between MTB lineages therefore local data is required describe different strain populations. We used whole genome sequencing (WGS) characterize 37 extensively drug-resistant (XDR) isolates from...

10.1371/journal.pone.0117771 article EN cc-by PLoS ONE 2015-02-26

Combating the spread of drug resistant tuberculosis is a global health priority. Whole genome association studies are being applied to identify genetic determinants resistance anti-tuberculosis drugs. Protein structure and interaction modelling used understand functional effects putative mutations provide insight into molecular mechanisms leading resistance.To investigate potential utility these approaches, we analysed genomes 144 Mycobacterium clinical isolates from The Special Programme...

10.1186/s12916-016-0575-9 article EN cc-by BMC Medicine 2016-02-16

Whole-genome sequencing (WGS) can be used in genomic epidemiology investigations to confirm or refute outbreaks of bacterial pathogens, and support targeted efficient infection control interventions. We aimed define a genetic relatedness cutoff, quantified as number single-nucleotide polymorphisms (SNP), for meticillin-resistant Staphylococcus aureus (MRSA), above which recent (ie, within 6 months) patient-to-patient transmission could ruled out.We did retrospective epidemiological analysis...

10.1016/s2666-5247(20)30149-x article EN cc-by The Lancet Microbe 2020-12-01

Tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) is the second major cause of death from an infectious disease worldwide. Recent advances in DNA sequencing are leading to ability generate whole genome information clinical isolates M. complex (MTBC). The identification informative genetic variants such as phylogenetic markers and those associated with drug resistance or virulence will help barcode Mtb context epidemiological, diagnostic studies. genomic datasets increasingly...

10.1016/j.tube.2014.02.005 article EN cc-by Tuberculosis 2014-02-15

Vancomycin-resistant Enterococcus faecium (VREfm) is a leading cause of nosocomial infection. Here, we describe the utility whole-genome sequencing in defining VREfm transmission.

10.1093/cid/ciw872 article EN cc-by Clinical Infectious Diseases 2017-01-04

Approximately 10% of the Mycobacterium tuberculosis genome is made up two families genes that are poorly characterized due to their high GC content and highly repetitive nature. The PE PPE typified by conserved N-terminal domains incorporate proline-glutamate (PE) proline-proline-glutamate (PPE) signature motifs. They hypothesised be important virulence factors involved with host-pathogen interactions, but genetic variability complexity analysis means they typically disregarded in studies.To...

10.1186/s12864-016-2467-y article EN cc-by BMC Genomics 2016-02-28

BackgroundDNA sequencing could become an alternative to in vitro antibiotic susceptibility testing (AST) methods for determining resistance by detecting genetic determinants associated with decreased susceptibility. Here, we aimed assess and improve the accuracy of determination from Enterococcus faecium genomes diagnosis surveillance purposes.MethodsIn this retrospective diagnostic study, first conducted a literature search PubMed on Jan 14, 2021, compile catalogue genes mutations...

10.1016/s2666-5247(23)00297-5 article EN cc-by The Lancet Microbe 2024-01-11

Although Bacillus Calmette-Guérin (BCG) vaccines against tuberculosis have been available for more than 90 years, their effectiveness has hindered by variable protective efficacy and a lack of lasting memory responses. One factor contributing to this variability may be the diversity BCG strains that are used around world, in part from genomic changes accumulated during vaccine production resulting differences gene expression. We compared genomes transcriptomes global collection fourteen most...

10.1038/srep15443 article EN cc-by Scientific Reports 2015-10-21

Abstract Summary: Spoligotyping is a well-established genotyping technique based on the presence of unique DNA sequences in Mycobacterium tuberculosis (Mtb), causal agent disease (TB). Although advances sequencing technologies are leading to whole-genome bacterial characterization, tens thousands isolates have been spoligotyped, giving global view Mtb strain diversity. To bridge gap, we developed SpolPred, software predict spoligotype from raw sequence reads. Our approach compared with...

10.1093/bioinformatics/bts544 article EN cc-by-nc Bioinformatics 2012-09-26

Background Understanding the emergence and spread of multidrug-resistant tuberculosis (MDR-TB) is crucial for its control. MDR-TB in previously treated patients generally attributed to selection drug resistant mutants during inadequate therapy rather than transmission a strain. Traditional genotyping methods are not sufficient distinguish strains populations with high burden it has been difficult assess degree these settings. We have used whole genome analysis investigate M. isolated from...

10.1371/journal.pone.0083012 article EN cc-by PLoS ONE 2013-12-11

Abstract Background Antibiotics remain the cornerstone of modern medicine. Yet there exists an inherent dilemma in their use: we are able to prevent harm by administering antibiotic treatment as necessary both humans and animals, but must be mindful limiting spread resistance safeguarding efficacy antibiotics for current future generations. Policies that strike right balance informed a transparent rationale relies on robust evidence base. Main text One way generate base needed inform...

10.1186/s12879-019-4630-y article EN cc-by BMC Infectious Diseases 2019-11-29

Antibiotic resistance hinders the treatment of bacterial infection. To guide effective therapy, clinical microbiology laboratories routinely perform susceptibility testing to determine antibiotic sensitivity an infecting pathogen. This approach relies on assumption that it can reliably distinguish bacteria capable expressing in patients, idea challenged by present study. We report important human pathogen Staphylococcus aureus frequently carries genes have become inactivated (“silenced”)...

10.1128/mbio.01755-19 article EN cc-by mBio 2019-10-29

Multidrug- (MDR) and extensively drug resistant (XDR) tuberculosis (TB) presents a challenge to disease control elimination goals. In Lisbon, Portugal, specific successful XDR-TB strains have been found in circulation for almost two decades. the present study we genotyped sequenced genomes of 56 Mycobacterium isolates recovered mostly from Lisbon. The genotyping data revealed three major clusters associated with MDR-TB, which are XDR-TB. Whilst genomic contributed elucidate phylogenetic...

10.1186/1471-2164-15-991 article EN cc-by BMC Genomics 2014-11-18
Coming Soon ...